Schizophenia Drugs

Exciting claims about what 'atypical' antipsychotic drugs can do are marred by the poor quality of much of the research evidence, say Paul Wilson, Simon Gilbody and Anne-Marie Bagnall

You need to be an HSJ subscriber to read more


Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to
  • The HSJ app

Enquire about multi-user access